Request Your Free White Paper Now:

"BioCode STI + Resistance Panel (RUO) Application Note"

This application note from Applied BioCode describes the performance of the BioCode STI + Resistance Panel (RUO), which can simultaneously detect nucleic acids from bacterial and protozoan pathogens -- as well as SNP mutations associated with treatment resistance -- directly from clinical specimens.

Emerging resistance among pathogens that cause STIs is a major public health concern. Overuse or inappropriate use of antibiotics can contribute to the development of antibiotic-resistant strains of bacteria. Therefore, healthcare providers need to be cautious when prescribing antibiotics for STIs and should consider factors such as antibiotic resistance patterns in the community and individual patient factors. The simultaneous detection of potential pathogens and their associated drug resistance markers directly from clinical specimens is the most rapid means to both diagnose the infection and direct effective therapy for improved patient outcomes.

Offered Free by: Applied Biocode
See All Resources from: Applied Biocode